Press Releases
 
Brugada Syndrome Treatment Market Growth Opportunities & Technology Developments by 2026

Transparency Market Research Report Added "Brugada Syndrome Treatment Market" to its database.

albany , Ny, 19 February 2019 -- Rise in prevalence of Brugada syndrome is anticipated to drive the global Brugada syndrome treatment market during the forecast period. Increase in government prioritization of drugs for rare disorders is also expected to propel the global market in the near future.

Brugada syndrome is a life-threatening heart rhythm disorder. It causes a disruption of the normal rhythm in the heart’s lower chambers. It can be caused by a mutation, most commonly of the SCN5A gene. In some cases, researchers are unable to identify the primary cause of Brugada syndrome. ##### men are frequently diagnosed with the syndrome as compared to women. However, young children and adolescents are diagnosed at the same rate.

Signs and symptoms of Brugada syndrome include dizziness, gasping, and labored breathing particularly at night, sudden cardiac arrest, and syncope. The major risk factors of Brugada syndrome include fever, family history, and race. Common complications of the syndrome are sudden cardiac arrest and fainting (syncope).

Report Overview @ https://www.transparencymarketresearch.com/brugada-syndrome-treatment-market.html

Cardiologists or professionals can diagnose Brugada syndrome based on medical history and tests. The common diagnostic tests are electrocardiogram (ECG) with medication, genetic testing, and electrophysiology (EP) test. Brugada syndrome treatment depends on the risk of an abnormal heartbeat. Based on the risk of an abnormal heartbeat, doctors recommend medical device and drug therapy. Implantable cardioverter-defibrillators are implanted subpectorally or subcutaneously into the right ventricle or right atrium.

Rise in prevalence of Brugada syndrome is anticipated to drive the global Brugada syndrome treatment market during the forecast period. Increase in government prioritization of drugs for rare disorders is also expected to propel the global market in the near future. Moreover, shortage of cardiovascular health care experts in Latin America and Middle East & Africa hampers the growth of the Brugada syndrome treatment market in these regions. Organizations supporting the treatment of this syndrome globally are the Genetic and Rare Diseases (GARD) Information Center and Sudden Arrhythmia Death Syndromes Foundation.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=57738

The global Brugada syndrome treatment market can be segmented based on treatment, end-user, and region. In terms of treatment, the Brugada syndrome treatment market can be bifurcated into medical devices and drug therapy. Quinidine is a common antiarrhythmic drug for the treatment of Brugada syndrome. Implantable cardioverter-defibrillator (ICD) is a medical device for the treatment of the syndrome. ICD is the primary treatment for the syndrome. This device continuously monitors the heart rhythm and delivers electrical shocks to control abnormal heartbeats.

In terms of end-user, the global Brugada syndrome treatment market can be divided into hospitals and special clinics. The hospitals segment held significant share of the market in 2017.

Based on region, the global Brugada syndrome treatment market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for major share of the global market in 2017, followed by Europe and Asia Pacific. The U.S. held significant share of the Brugada syndrome treatment market in North America in terms of revenue in 2017. The market in Asia Pacific is growing rapidly due to increase in the number of patients suffering from the disorder. Better health care infrastructure, economic growth, rise in the number of insurance payers, expanding & developing private health care sector, and increase in awareness among people about Brugada syndrome treatment are expected to propel the Brugada syndrome treatment market in the region in the next few years. The Brugada syndrome treatment market in Latin America and Middle East & Africa is projected to expand at a moderate growth rate from 2018 to 2026.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=57738

Key players operating in the global Brugada syndrome treatment market include Boston Scientific Corporation, LivaNova plc, Medtronic, Abbott, Edwards Lifesciences Corporation, Novartis AG, Sun Pharmaceutical Industries Ltd., MRI Interventions, and HeartSine Technologies LLC. In term of revenue, Medtronic, Boston Scientific Corporation, and LivaNova plc dominated the market in 2017.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email:

Website: https://www.transparencymarketresearch.com

# # #


Submitted by hawer on Tuesday, 19 February 2019 at 7:12 PM
Category: Health Care & Medical
 
Related News

Hypoparathyroidism Treatment Market Market Report 2016 and Future Opportunity Assessment 2027
Tuesday, 26 Mar 2019

Antidiuretics Market Research Key Players, Industry Overview and Forecasts to 2024
Tuesday, 26 Mar 2019

Vascular Trauma Management Market Market Competitive Landscape Analysis with Forecast by 2025
Tuesday, 26 Mar 2019

Diabetic Retinopathy Market Overview and Regional Outlook Study 2017 - 2025
Tuesday, 26 Mar 2019

Onchocerciasis Treatment Market Market Growth Opportunities & Technology Developments by 2025
Tuesday, 26 Mar 2019

Related Events

Diagnostic Imaging Update on Kauai
Monday, 25 Mar 2019

8th Drug Formulation and Bioavailability
Monday, 25 Mar 2019

Slow- and Controlled-Release and Stabilized Fertilizers (SCRSFs)
Monday, 25 Mar 2019

3rd Product Complaints Forum
Monday, 25 Mar 2019

Bacteriophage Therapy Summit
Tuesday, 26 Mar 2019

Latest News

Electronics at the nanoscale: challenges and opportunities for making metal nanowires
Tuesday, 26 Mar 2019

Hypoparathyroidism Treatment Market Market Report 2016 and Future Opportunity Assessment 2027
Tuesday, 26 Mar 2019

Antidiuretics Market Research Key Players, Industry Overview and Forecasts to 2024
Tuesday, 26 Mar 2019

Vascular Trauma Management Market Market Competitive Landscape Analysis with Forecast by 2025
Tuesday, 26 Mar 2019

Diabetic Retinopathy Market Overview and Regional Outlook Study 2017 - 2025
Tuesday, 26 Mar 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Tuesday, 26 March 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: CCISDA Spring Conference 2019
  • Diagnostic Imaging Update on Kauai
  • Gulf Safety Forum 2019
  • 2nd Pharmacovigilance Audit and Inspection Conference
  • 8th Drug Formulation and Bioavailability

  • Latest Jobs
    Sorry, there are currently no entries posted here.